Tapewire

Nasdaq · USD

BMRN

BIOMARIN PHARMACEUTICAL INC

Export transactions ↓
Tapewire entity
2404
SEC CIK
0001048477
Parsed reports
685

Last 12 months

Inside the activity.

0 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202601
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 20, 2021 Filed Oct 22, 2021 20:36 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 1,000 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001567619-21-018613 · doc1.xml · derivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,000

Underlying: Common Stock · 1,000 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
October 20, 2021 Filed Oct 22, 2021 20:36 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,000 $37.46 $37,460.00
Disclosure

SEC source: 0001567619-21-018613 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 305,839

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 09, 2021 Filed Dec 3, 2021 02:42 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
OtherCommon Stock 50 $78.77 $3,938.50
Disclosure

SEC source: 0001567619-21-021536 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 305,889

Read SEC document
August 02, 2021 Filed Aug 4, 2021 20:59 UTC
Davis George EricEVP, General Counsel
SaleCommon Stock 5,518 $76.69 $423,175.42
Disclosure

SEC source: 0001567619-21-014415 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,590

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 12, 2021.

Read SEC document
July 16, 2021 Filed Jul 20, 2021 00:55 UTC
Acosta AndreaGVP, Chief Accounting Officer
Tax withholdingCommon Stock 285 $78.84 $22,469.40
Disclosure

SEC source: 0001567619-21-013664 · doc1.xml · nonDerivative · entry 2

Acosta Andrea · CIK 0001818518 · GVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,122

Read SEC document
June 29, 2021 Filed Jul 1, 2021 00:18 UTC
Mueller BrianEVP, Chief Financial Officer
Tax withholdingCommon Stock 576 $83.46 $48,072.96
Disclosure

SEC source: 0001567619-21-012800 · doc1.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,781

Read SEC document
June 21, 2021 Filed Jun 23, 2021 21:04 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 1,000 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001567619-21-012534 · doc1.xml · derivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,000

Underlying: Common Stock · 1,000 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
June 21, 2021 Filed Jun 23, 2021 21:04 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,000 $37.46 $37,460.00
Disclosure

SEC source: 0001567619-21-012534 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 304,839

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 25, 2021 Filed May 28, 2021 00:05 UTC GrantCommon Stock 5,120 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-011320 · doc1.xml · nonDerivative · entry 1

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,860

F1 · price: Restricted stock units granted on May 25, 2021. Price not applicable.

Read SEC document
May 25, 2021 Filed May 28, 2021 00:44 UTC GrantCommon Stock 5,120 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-011326 · doc1.xml · nonDerivative · entry 1

Slamon Dennis · CIK 0001603265 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,035

F1 · price: Restricted stock units granted on May 25, 2021. Price not applicable.

Read SEC document
May 25, 2021 Filed May 27, 2021 23:29 UTC GrantCommon Stock 5,120 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-011316 · doc1.xml · nonDerivative · entry 1

MEIER RICHARD A · CIK 0001227305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,392

F1 · price: Restricted stock units granted on May 25, 2021. Price not applicable.

Read SEC document
May 25, 2021 Filed May 27, 2021 23:02 UTC GrantCommon Stock 5,120 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-011314 · doc1.xml · nonDerivative · entry 1

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,970

F1 · price: Restricted stock units granted on May 25, 2021. Price not applicable.

Read SEC document
May 25, 2021 Filed May 27, 2021 22:34 UTC GrantCommon Stock 5,120 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-011309 · doc1.xml · nonDerivative · entry 1

HOMBACH ROBERT J. · CIK 0001496182 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,330

F1 · price: Restricted stock units granted on May 25, 2021. Price not applicable.

Read SEC document
May 25, 2021 Filed May 27, 2021 21:57 UTC
Ho MaykinDirector
GrantCommon Stock 5,120 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-011306 · doc1.xml · nonDerivative · entry 1

Ho Maykin · CIK 0001646395 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,470

F1 · price: Restricted stock units granted on May 25, 2021. Price not applicable.

Read SEC document
May 25, 2021 Filed May 27, 2021 21:37 UTC GrantCommon Stock 5,120 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-011303 · doc1.xml · nonDerivative · entry 1

HERON ELAINE J · CIK 0001235471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,088

F1 · price: Restricted stock units granted on May 25, 2021. Price not applicable.

Read SEC document
May 25, 2021 Filed May 27, 2021 21:20 UTC GrantCommon Stock 5,120 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-011288 · doc1.xml · nonDerivative · entry 1

Dere Willard H · CIK 0001311569 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,410

F1 · price: Restricted stock units granted on May 25, 2021. Price not applicable.

Read SEC document
May 25, 2021 Filed May 27, 2021 20:12 UTC GrantCommon Stock 5,120 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-011257 · doc1.xml · nonDerivative · entry 1

ANDERSON ELIZABETH M · CIK 0001758247 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,910

F1 · price: Restricted stock units granted on May 25, 2021. Price not applicable.

Read SEC document
May 10, 2021 Filed May 12, 2021 23:21 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 8,513 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001567619-21-009745 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,513 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
May 10, 2021 Filed May 12, 2021 23:21 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 8,513 $77.29 $657,969.77
Disclosure

SEC source: 0001567619-21-009745 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,839

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.

Read SEC document
May 10, 2021 Filed May 12, 2021 23:21 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 8,513 $26.49 $225,509.37
Disclosure

SEC source: 0001567619-21-009745 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 312,352

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.

Read SEC document
May 07, 2021 Filed May 11, 2021 01:07 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 25,000 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001567619-21-009481 · doc1.xml · derivative · entry 11

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,513

Underlying: Common Stock · 25,000 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.

F9 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
May 07, 2021 Filed May 11, 2021 01:07 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 3,329 $79.39 $264,302.63
Disclosure

SEC source: 0001567619-21-009481 · doc1.xml · nonDerivative · entry 8

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,839

F2 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.

F7 · date: The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 100 shares, with the reporting person's purchase of shares at a price of $77.9400 on March 4, 2021. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.

F8 · price: The price in column 4 is the weighted average price. The price actually received ranged from $79.15 to $79.75. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
May 07, 2021 Filed May 11, 2021 01:07 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 6,115 $78.77 $481,672.44
Disclosure

SEC source: 0001567619-21-009481 · doc1.xml · nonDerivative · entry 7

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,168

F2 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.

F6 · price: The price in column 4 is the weighted average price. The price actually received ranged from $78.15 to $79.14. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
May 07, 2021 Filed May 11, 2021 01:07 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 15,556 $77.60 $1,207,145.60
Disclosure

SEC source: 0001567619-21-009481 · doc1.xml · nonDerivative · entry 6

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 313,283

F2 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.

F5 · price: The price in column 4 is the weighted average price. The price actually received ranged from $77.13 to $77.95. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
May 07, 2021 Filed May 11, 2021 01:07 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 25,000 $26.49 $662,250.00
Disclosure

SEC source: 0001567619-21-009481 · doc1.xml · nonDerivative · entry 5

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,839

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.

Read SEC document
May 07, 2021 Filed May 11, 2021 23:42 UTC
Mueller BrianEVP, Chief Financial Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 6,709 $0.00 Strike: $28.23 $0.00
Disclosure

SEC source: 0001567619-21-009606 · doc1.xml · derivative · entry 4

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,709 shares

Expires 2021-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on January 29, 2021.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
May 07, 2021 Filed May 11, 2021 23:42 UTC
Mueller BrianEVP, Chief Financial Officer
SaleCommon Stock 6,709 $79.50 $533,365.50
Disclosure

SEC source: 0001567619-21-009606 · doc1.xml · nonDerivative · entry 3

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,357

F2 · date: Trade made pursuant to a 10b5-1 plan executed on January 29, 2021.

Read SEC document
May 07, 2021 Filed May 11, 2021 23:42 UTC
Mueller BrianEVP, Chief Financial Officer
Exercise / conversionCommon Stock 6,709 $28.23 $189,395.07
Disclosure

SEC source: 0001567619-21-009606 · doc1.xml · nonDerivative · entry 2

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,066

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on January 29, 2021.

Read SEC document
May 06, 2021 Filed May 7, 2021 23:48 UTC Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 15,000 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001567619-21-009351 · doc1.xml · derivative · entry 3

MEIER RICHARD A · CIK 0001227305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
May 06, 2021 Filed May 7, 2021 23:48 UTC SaleCommon Stock 5,068 $78.38 $397,245.04
Disclosure

SEC source: 0001567619-21-009351 · doc1.xml · nonDerivative · entry 2

MEIER RICHARD A · CIK 0001227305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,272

F1 · price: The price in column 4 is the weighted average price. The price actually received ranged from $78.38 to $78.405. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
May 06, 2021 Filed May 7, 2021 23:48 UTC Exercise / conversionCommon Stock 15,000 $26.49 $397,350.00
Disclosure

SEC source: 0001567619-21-009351 · doc1.xml · nonDerivative · entry 1

MEIER RICHARD A · CIK 0001227305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,340

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 06, 2021 Filed May 11, 2021 01:07 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 25,000 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001567619-21-009481 · doc1.xml · derivative · entry 10

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,513

Underlying: Common Stock · 25,000 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.

F9 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
May 06, 2021 Filed May 11, 2021 01:07 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 10,175 $78.69 $800,670.75
Disclosure

SEC source: 0001567619-21-009481 · doc1.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,839

F2 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.

F4 · price: The price in column 4 is the weighted average price. The price actually received ranged from $78.38 to $78.99. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
May 06, 2021 Filed May 11, 2021 01:07 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 14,825 $78.01 $1,156,527.90
Disclosure

SEC source: 0001567619-21-009481 · doc1.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 314,014

F2 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.

F3 · price: The price in column 4 is the weighted average price. The price actually received ranged from $77.375 to $78.37. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
May 06, 2021 Filed May 11, 2021 01:07 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 25,000 $26.49 $662,250.00
Disclosure

SEC source: 0001567619-21-009481 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,839

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.

Read SEC document
May 04, 2021 Filed May 6, 2021 00:46 UTC
Guyer Charles GregEVP, Chief Technical Officer
Tax withholdingCommon Stock 3,986 $78.35 $312,303.10
Disclosure

SEC source: 0001567619-21-009154 · doc1.xml · nonDerivative · entry 2

Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,695

Read SEC document
May 03, 2021 Filed May 5, 2021 00:27 UTC
Davis George EricEVP, General Counsel
SaleCommon Stock 2,089 $78.30 $163,568.70
Disclosure

SEC source: 0001567619-21-009021 · doc1.xml · nonDerivative · entry 3

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,108

F2 · date: Trade made pursuant to a 10b5-1 plan executed on March 12, 2021.

Read SEC document
May 03, 2021 Filed May 5, 2021 00:27 UTC
Davis George EricEVP, General Counsel
SaleCommon Stock 2,584 $78.30 $202,327.20
Disclosure

SEC source: 0001567619-21-009021 · doc1.xml · nonDerivative · entry 2

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,197

F2 · date: Trade made pursuant to a 10b5-1 plan executed on March 12, 2021.

Read SEC document
April 30, 2021 Filed May 4, 2021 00:24 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 1,000 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001567619-21-008885 · doc1.xml · derivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,000

Underlying: Common Stock · 1,000 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
April 30, 2021 Filed May 4, 2021 00:24 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,000 $37.46 $37,460.00
Disclosure

SEC source: 0001567619-21-008885 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,498

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 30, 2021 Filed May 5, 2021 00:27 UTC
Davis George EricEVP, General Counsel
GrantCommon Stock 341 $62.41 $21,280.79
Disclosure

SEC source: 0001567619-21-009021 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,781

F1 · date: Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 30, 2021 Filed May 6, 2021 00:46 UTC
Guyer Charles GregEVP, Chief Technical Officer
GrantCommon Stock 221 $62.41 $13,791.95
Disclosure

SEC source: 0001567619-21-009154 · doc1.xml · nonDerivative · entry 1

Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,681

F1 · date: Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 30, 2021 Filed May 11, 2021 01:07 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GrantCommon Stock 341 $62.41 $21,280.79
Disclosure

SEC source: 0001567619-21-009481 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,839

F1 · date: Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 30, 2021 Filed May 11, 2021 23:42 UTC
Mueller BrianEVP, Chief Financial Officer
GrantCommon Stock 341 $62.41 $21,280.79
Disclosure

SEC source: 0001567619-21-009606 · doc1.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,357

F1 · date: Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 30, 2021 Filed Jul 20, 2021 00:55 UTC
Acosta AndreaGVP, Chief Accounting Officer
GrantCommon Stock 271 $62.41 $16,912.30
Disclosure

SEC source: 0001567619-21-013664 · doc1.xml · nonDerivative · entry 1

Acosta Andrea · CIK 0001818518 · GVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,407

F1 · date: Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 30, 2021 Filed Oct 28, 2021 23:48 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
GrantCommon Stock 342 $62.41 $21,343.19
Disclosure

SEC source: 0001567619-21-018936 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,592

F1 · date: Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 30, 2021 Filed Feb 12, 2022 02:29 UTC
FUCHS HENRY JPresident, Worldwide R&D
GrantCommon Stock 341 $62.41 $21,280.79
Disclosure

SEC source: 0001567619-22-003783 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,483

F1 · date: Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 23, 2021 Filed Apr 27, 2021 00:44 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 10,000 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001567619-21-008607 · doc1.xml · derivative · entry 7

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,513

Underlying: Common Stock · 10,000 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
April 23, 2021 Filed Apr 27, 2021 00:44 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 10,000 $79.34 $793,400.00
Disclosure

SEC source: 0001567619-21-008607 · doc1.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 302,498

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.

F2 · date: The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 100 shares, with the reporting person's purchase of shares at a price of $77.9400 on March 4, 2021. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.

Read SEC document
April 23, 2021 Filed Apr 27, 2021 00:44 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 10,000 $26.49 $264,900.00
Disclosure

SEC source: 0001567619-21-008607 · doc1.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 312,498

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.